Kopran LimitedNSE: KOPRAN

Kopran Limited has informed the Exchange regarding a press release dated October 22, 2026, titled " Closure of Medicine Authority European Union (EU)- conducted GMP inspection at the Company s Formulation manufacturing facility located at Khopoli. ".

· Issued by Kopran Limited via NSE India

Filed with NSE · ISIN INE082A01010 ·

On 6ix: 6ix.com/news/kopran-limited-has-informed-the-exchange-regarding-a-press-release-dated-october-22-2026-titled-closure-of-medicine-authority-european-union-eu-conducted-gmp-inspection-at-the-company-s-formulation-manufacturing-facility-located-at-khopoli

Kopran Limited

View Attachment

6ix is reading this filing.

View original source (NSE India)Kopran Limited on 6ix

Earlier from Kopran

All Kopran news releases